SN-38 Glucuronide is a metabolite of the anticancer drug irinotecan, used in pharmaceutical and biochemical research. It plays a crucial role in studying the drug’s metabolism, detoxification, and excretion processes. This compound is essential for understanding the pharmacokinetics and therapeutic efficacy of irinotecan, as well as its side effects. Researchers rely on SN-38 Glucuronide for precise and reliable results in advanced cancer research and drug development, contributing significantly to the optimization of chemotherapeutic treatments.
| Catalog Number | R013003 |
| CAS Number | 121080-63-5 |
| Synonyms | 4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl β-D-Glucopyranosiduronic Acid; (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl β- |
| Molecular Formula | C28H28N2O11 |
| Purity | 95% |
| Storage | -20°C |
| InChIKey | SSJQVDUAKDRWTA-CAYKMONMSA-N |
